Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice
International Journal of Rheumatic Diseases - United Kingdom
doi 10.1111/1756-185x.13512
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 14, 2019
Authors
Publisher
Wiley